t
Iofina plc reported record crystalline iodine production of 743.2 metric tonnes for FY 2025, an increase of 17.2% from FY24, and 437.6 MT for H2 2025. The Company expects FY 2025 revenues to surpass $65m and EBITDA to be greater than $11m, with net cash at $5.2m as of 31 December 2025. Iofina also targets crystalline iodine production of 325-355 MT for H1 2026 and expects a new Permian Basin plant to begin operations in H2 2026.
| Date | 13 Jan 2026 |
| Time | 07:00:05 |
| Category | Corporate updates |
| ID | 5982O |
13 January 2026
Iofina plc
("Iofina", the "Company" or the "Group")
(AIM: IOF)
Q4 2025 Corporate Update
Another Record Year of Iodine Production
FY 2025 Revenue and EBITDA expected to Exceed Market Expectations1
Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, today provides a market update regarding its activities during Q4 2025 (the "Period") and for the full year ended 31 December 2025.
In the Period, Iofina Resources produced 221.8 metric tonnes ("MT") of crystalline iodine from its eight IOsorb® plants in Central and Northwest Oklahoma (Q4 2024: 194.1 MT). Total crystalline iodine production during the second half of 2025 reached a record 437.6 MT (H2 2024: 358.0 MT), achieving the upper end of the Company's stated production guidance of 400-440 MT. Total crystalline iodine production for 2025 was a record 743.2 MT, up 17.2% from FY24 (FY24: 634.1 MT).
As a result of achieving the upper end of its production forecast along with a strong sales cycle in the second half of 2025, Iofina expects to exceed market expectations for revenue and EBITDA.1 Revenues for 2025 are projected to surpass $65m, and EBITDA for 2025 is expected to be greater than $11m. Additionally, the Company's net cash as at 31 December 2025 was $5.2m (FY24: $2.9m).
Regarding its growth projects, the Company continues to make progress on its next IOsorb® plant in the Permian Basin. The new plant is expected to process c.50,000 barrels of water, approximately twice the volume of the maximum brine throughput capacity of the existing Oklahoma IOsorb® plants, giving an annualised production target of 170-220MT. On current timelines, the operations team expects the new plant to be switched on in H2 2026.
The Company continues to advance its broader plant development pipeline and remains focused on delivering further production growth. The Company expects to produce between 325-355 MT of crystalline iodine in H1 2026 (H1 2025: 305.5MT). As previously communicated, the Company's iodine production is always second-half weighted due to the impact of winter conditions on the oil field, coupled with lower brine temperatures.
The spot iodine price was consistently above $70/kg throughout 2025, and the Company expects these market conditions to continue as we enter 2026 due to the continued robust global demand for iodine.
President and CEO, Dr. Tom Becker, commented:
"Iofina delivered another record year of production, reflecting the strength and consistency of our operations across all plants. The momentum in product sales experienced in H1 2025 continued throughout the second half of 2025. As a result, we expect full-year revenue and EBITDA to exceed current market expectations.
"Looking ahead, the Board is excited by the outlook for Iofina. We believe that the business is in a very strong position against a backdrop of increasing demand for its iodine products and our ongoing programme to continue expanding our iodine production capacity. Construction of our largest plant to date is underway in the Permian Basin, and we continue to execute our growth strategy, which we believe will result in another strong year in 2026 for Iofina. We look forward to providing further updates on the progress of the new plant and across the wider business in due course."
This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.
1For the purpose of this announcement, the Company believes market expectations for 2025 to be revenues of $62.8 million and EBITDA $10.5 million.
Enquiries:
Iofina plc
Dr. Tom Becker
CEO & President
Tel: +44 (0)20 3006 3135
Nomad & Broker:
Canaccord Genuity Limited
Henry Fitzgerald-O'Connor/Harry Rees
Tel: +44 (0)20 7523 8000
Financial PR and Media Contact:
Yellow Jersey PR Limited
Charles Goodwin/Shivantha Thambirajah/Maya Brookes
Tel: +44 (0)7747 788 221/+44 (0)7983 521 488
About Iofina:
Iofina plc (AIM: IOF) is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities Iofina Resources and Iofina Chemical.
LEI: 213800QDMFYVRJYYTQ84
ISIN: GB00B2QL5C79
Iofina Resources
Iofina Resources develops, builds, owns, and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina operates eight IOsorb® plants in Oklahoma and consistently uses technology and innovation to improve and expand its operations.
Iofina Chemical
Iofina Chemical has manufactured high-quality halogen speciality chemicals derived from raw iodine, as well as non-iodine-based products. Iofina Chemical celebrated its 40th anniversary in 2023 as a preeminent halogen-based specialty chemicals company.